Broncus Holding Corporation (02216.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

Market Cap

HKD 307.19M

MomentumView details →

1D Return

−0.78%

YTD Return

−73.32%

RSI (14)

49.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

Market Cap

HKD 307.19M

RSI (14)

49.1

MomentumView details →

1D Return

−0.78%

YTD Return

−73.32%

ProfitabilityView details →

Gross Margin

25.04%

Net Margin

−423.43%

EBITDA Margin

−520.03%

ROE (TTM)

−23.36%

ROA (TTM)

−22.16%

Asset Turnover

0.05x

GrowthView details →

Revenue YoY

−60.89%

EPS YoY

+30.36%

FCF YoY

+69.58%

Revenue CAGR 3Y

−73.56%

EPS CAGR 3Y

−17.89%

EBITDA YoY

+27.12%

EarningsView details →

EPS (Actual)

−HKD 0.16

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

15.43x

Quick Ratio

14.96x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

7.88M

Net Income (TTM)

−33.37M

Op. CF (TTM)

−15.05M

Next earningsMar 31, 2027 →

Latest newsMore news →

Broncus Medical announced its interim results for the six months ended June 2026, with revenue of $3.288 million, up 99% year-on-year, and a widened net loss of $8.13 million compared to $7.792 million in the same period last year.8d ago

Broncus Medical-B announced that its self-developed BroncTru disposable bronchoscopic dilation catheter received EU MDR CE certification, marking progress in international registration and global product layout.39d ago

Similar companies

TriSalus Life Sciences, Inc.TLSI Treace Medical Concepts, Inc.TMCI Anika Therapeutics, Inc.ANIK Viemed Healthcare, Inc.VMD AVITA Medical, Inc.RCEL Standard BioTools Inc.LAB Find similar companies →

Latest newsMore news →

Broncus Medical announced its interim results for the six months ended June 2026, with revenue of $3.288 million, up 99% year-on-year, and a widened net loss of $8.13 million compared to $7.792 million in the same period last year.8d ago Broncus Medical-B announced that its self-developed BroncTru disposable bronchoscopic dilation catheter received EU MDR CE certification, marking progress in international registration and global product layout.39d ago